CD8α- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8α-and CD205 molecules

Journal of Experimental Medicine

Volumn 195, Issue 10, 2002, Pages 1233-1245

  Morón, Gabrie L ^a   Rueda, Paloma ^b   Casal, Ignacio ^b   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

^b SA   (Spain)

Author keywords

Cross priming; CTL; Dendritic cells; Exogenous antigens; Virus like particles

Indexed keywords

ANTIGEN; CD11B ANTIGEN; CD205 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; UNCLASSIFIED DRUG; CD4 ANTIGEN; CELL SURFACE RECEPTOR; DEC 205 RECEPTOR; DEC-205 RECEPTOR; DNA BINDING PROTEIN; LECTIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; OVALBUMIN; RAG2 PROTEIN, MOUSE; V(D)J RECOMBINATION ACTIVATING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GENE ACTIVATION; GENETIC RECOMBINATION; IMMUNE RESPONSE; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; VIRUS PARTICLE; ANIMAL; CD8+ T LYMPHOCYTE; CYTOLOGY; DOWN REGULATION; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PORCINE PARVOVIRUS; SPLEEN; UPREGULATION; VIRION; VIROLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; LECTINS, C-TYPE; MACROPHAGE-1 ANTIGEN; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; OVALBUMIN; PARVOVIRUS, PORCINE; RECEPTORS, CELL SURFACE; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION; VIRION;

EID: 0037140550     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011930     Document Type: Article

References (52)

1. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming
2. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
3. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
4. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo
5. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
6. Processing of engulfed apoptotic bodies yields T cell epitopes
7. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
8. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
9. Antigen presentation to CD8(+) T cells: Cross-priming in infectious diseases
10. Salmonella infection of bone marrow-derived macrophages and dendritic cells: Influence on antigen presentation and initiating an immune response
11. Dendritic cells: Multi-lineal and multi-functional
12. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen
13. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse
14. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
15. - dendritic cells cross-prime cytotoxic T cells in vivo
16. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo
17. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: Enhanced memory response by boosting with recombinant vaccinia virus
18. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
19. Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells
20. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes
21. Human dendritic cells are activated by chimeric humman papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro
22. Papillomavirus-like particles induce acute activation of dendritic cells
23. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles
24. Porcine parvovirus: DNA sequence and genome organization
25. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity
26. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles
27. Production of porcine and canine parvovirus-like particles using recombinant baculovirus
28. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens
29. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells
30. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
31. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
32. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant
33. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses
34. A new foreign policy: MHC class I molecules monitor the outside world
35. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
36. Recycling MHC class I molecules and endosomal peptide loading
37. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
38. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation
39. Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo
40. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation
41. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
42. Cross-presentation, dendritic cells, tolerance and immunity
43. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
44. + T cell help
45. Dendritic cell regulation of TH1-TH2 development
46. Modulating the immune response with dendritic cells and their growth factors
47. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells
48. Cutting edge: Intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells
49. CTL priming by CD8(+) and CD8(-) dendritic cells in vivo
50. CD8alpha(+) dendritic cells originate from the CD8alpha(-) dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation
51. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
52. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice